Singapore, Malaysia Agree to Joint Inspections, Information Exchange

Singapore’s Health Sciences Authority (HSA) and Malaysia’s National Pharmaceutical Control Board (NPCB) will exchange drug registration assessment reports and conduct joint inspections of manufacturing plants under a March 27 memorandum of understanding. The MOU seeks to strengthen, promote and develop cooperation in regulatory science, enforcement, postmarket surveillance, good manufacturing practices and good clinical practices, the agencies said.
International Pharmaceutical Regulatory Monitor